labor induction placenta accreta placenta previa pregnancy uterine artery embolization a b s t r a c t Objective: To summarize our experiences in the treatment of labor induction in placenta previa using uterine artery embolization. Case report: We retrospectively analyzed the clinical data of seven patients with placenta previa who underwent antepartum uterine artery embolization before vaginal delivery. After antepartum embolization, five patients with placenta previa had successful vaginal deliveries and two cases of placenta previa with accreta underwent emergency hysterectomy. Some complications were reported in this experience. The follow-up study showed that most patients resumed their normal menstruation and some of them were able to conceive. Conclusion: For the management of placenta previa, uterine artery embolization is a minimally invasive technique that helps to avoid cesarean section. The impact on menstruation and fertility is yet to be seen.
Introduction
The placenta begins to develop after blastocyst implantation into the endometrium. In some cases, the placenta is implanted in the lower uterine segment close to or even covering the internal cervix os, or invades through the endometrium and myometrium, which causes placenta previa and placenta accreta, respectively [1] , which may lead to hemorrhage when vaginal delivery is attempted. Arterial embolization was first described by Brown et al [2] to control postpartum bleeding. We present our experiences with induction of labor for placenta previa with the help of antepartum uterine artery embolization (UAE).
Material and methods
A retrospective analysis of UAE performed for the management of abnormal placental implantation was carried out from November 2007 to December 2012. Abnormal placental implantation was preoperatively diagnosed using ultrasonography (USG), magnetic resonance imaging (MRI) or both. According to the diagnosis, all the patients were divided into two groups: placenta previa (PP) and placenta previa with accrete (PPþPA). In the PP group, all patients were diagnosed with total placenta previa using USG, within gestational age 22e29 weeks. These patients chose the vaginal route to terminate their pregnancy because of fetal death and serious fetal malformations. In the PAþPP group, gestational age was within 21e22 weeks, and was diagnosed as total placenta previa with placenta accreta with the aid of USG and MRI; patients desired to terminate the pregnancy because of persistent vaginal bleeding. All patients gave informed consent for their management.
Ethacridine lactate (Rivanol) amniotic induction was performed in five patients with placenta previa and in two patients with placenta previa with accreta soon after they received antepartum embolization. The contractile effect of ethacradine lactate is mediated through the activation of mast cells in the myometrium that release mediators, such as prostaglandin F2a, prostaglandin E2, prostacyclin, and thromboxane A2 [3] .
This procedure was performed using a 5-Fr Cobra catheter (TERUMO, HangZhou, China) via a femoral artery approach. Embolization of both uterine arteries was carried out preferentially using pledgets of absorbable gelatin sponge (Elatine Sponge, NanJing, China), as well as Fibre Steel Coil (Cordis Corporation). For the PP and PPþPA groups, ethacridine lactate amniotic induction was performed after antepartum embolization. For the PPþPA group, methotrexate was injected into the uterine arteries before blocking the vessels with gelatin sponge. We confirmed all the patient's vital signs were stable and that coagulation profiles were normal before embolization.
Results
All the placenta previa cases, who received antepartum embolization and ethacridine lactate amniotic induction, had successful vaginal deliveries without excessive blood loss (Cases 1e5; Table 1 ). In the PPþPA group, one case of placenta accreta with previa (Case 6) also had vaginal delivery but with retained placenta. Case 7 underwent cesarean section because of uncontrolled bleeding during labor. Eventually, Cases 6 and 7 underwent emergency hysterectomy because of massive hemorrhage (total blood loss > 5 L in each case): one occurred at the time of placenta expulsion (1 month after delivery), and the other during labor. Placenta increta and percreta were diagnosed intraoperatively and a pathological examination on the hysterectomy specimens in both cases was performed. In Case 7, the placenta had invaded the bladder wall and partial cystectomy was performed, however, MRI did not disclose this finding before surgery.
Severe complications of UAE were reported in a few cases. One case in the PP group had femoral artery thrombosis due to long duration of catheterization. However, after thrombectomy and thrombolysis, the patient had a good outcome (Case 4; Table 1 ). Infection was a complication in patients with retained placenta. During subsequent clinical follow up by the obstetrician (from 3 months to 4 years), no midterm complications were reported.
During the follow-up study, we were able to contact the five patients with placenta previa. All five reported normal postpartum menstruation without any change in menstrual cycle and menstrual flow. Three patients conceived after their deliveries; among them, two patients had uneventful pregnancies and one asked for an abortion.
Discussion
Medical termination of midtrimester pregnancy with placenta previa has been reported [4] . Reviewing these articles, most terminations were carried out in the early second trimester, and there are no reports regarding third trimester termination. Pelvic arterial embolization to control obstetric hemorrhage was reported in succession [5, 6] . Therefore, in this study, we performed UAE in the patients with complete placenta previa following ethacridine lactate amniotic induction. UAE blocks the main blood supply of the placenta, hence reducing bleeding when vessels rupture during uterine contractions. From the outcome in our study, we concluded that UAE is an effective method to avoid cesarean section and hemorrhage in patients with placenta previa who need pregnancy termination.
With regard to the two cases of placenta previa with accreta, conservative management was unsuccessful, even though supported with adjuvant therapy, methotrexate, which acts by inducing placental necrosis and expediting placenta involution [7e10] . During the operation, we found that the placenta had already invaded the uterine wall, leading to placenta percreta. The reason for this may be the invasion of the uterine wall and posterior bladder wall by the placenta, and perfusion from the bladder artery. In this situation, UAE is not sufficient to block the blood supply completely to the placenta. Another possible reason may be due to continuous vascularization after embolization. Sherer et al [8] reported multiple bilateral UAE in patients with placenta previa percreta and the successful conservative management confirms this point.
Although UAE is effective for control of hemorrhage caused by placenta previa, a serious complication has been reported, namely, femoral artery thrombosis. We consider that the skilled technique described in the present study might be a measure to reduce this complication [11] . Infection was reported in our study, which can be controlled by prophylactic broad-spectrum antibiotic therapy.
With regard to the effect of embolization on the menstrual cycle, we showed that patients resumed their normal menstruation after 1e3 months, which was similar to the study of Descargues et al [12] . UAE provokes obliteration and reduction in uterine perfusion, thus, it is possible that uterine hypovascularization can induce some pregnancy complications later. In our study, there was the limitation of subsequent pregnancy after UAE, but it does not confirm that it was because of uterine hypovascularization that there was limitation of subsequent pregnancy. Randomized trials would be desirable to quell any future controversy [13] .
In conclusion, the advantages of UAE in the management of placenta previa have been established. Our study indicates that a woman who undergoes arterial embolization can resume her normal menstruation and reproduction. As long as long-term effects are concerned, more cases need to be studied.
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